Retatrutide · research summary

The Possible Hematological Cost of Metabolic Success: Do Incretin-Based Therapies Silently Trigger Anemia?

Medical sciences (Basel, Switzerland) · 2026. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.

Study type

Narrative review
“This narrative review aims to critically evaluate the available evidence regarding the potential association between incretin-based therapies and hematological changes.”

Subjects

Patients with diabetes mellitus and obesity, including those with chronic kidney disease and those undergoing weight-loss therapy
“Diabetes mellitus and obesity represent a growing global health burden with high morbidity and mortality.”

Reported findings

Current evidence is insufficient to establish a direct causal relationship or a class-wide adverse effect of incretin-based therapies on anemia.
“Although observational studies suggest possible associations with anemia, iron deficiency, and nutritional deficiencies in selected populations, current evidence is insufficient to establish a direct causal relationship or a class-wide adverse effect.”
The relationship between incretin-based therapies and hematological parameters is complex and heterogeneous, with findings differing across therapies, study populations, and outcomes.
“The available evidence indicates a complex and heterogeneous relationship between incretin-based therapies and hematological parameters, with findings differing across therapies, study populations, and outcomes.”
Potential pathophysiological explanations for hematological changes include micronutrient vulnerabilities due to reduced food intake, lower dietary diversity, gastrointestinal intolerance, delayed gastric emptying, and weight loss.
“Potential pathophysiological explanations include micronutrient vulnerabilities due to reduced food intake, lower dietary diversity, gastrointestinal intolerance, delayed gastric emptying, and weight loss.”

Limitations stated by the authors

The review is a narrative synthesis without formal risk-of-bias assessment or quantitative meta-analytic synthesis, and the included studies are heterogeneous in design and outcome definitions.
“As this was a narrative review, no formal risk-of-bias assessment or quantitative meta-analytic synthesis was performed; however, findings were interpreted according to study design, population characteristics, outcome definitions, and methodological limitations, and different levels of evidence were not considered equivalent.”

Source: PubMed 42783450 · DOI 10.3390/medsci14050577 · all study summaries

Reported findings

Current evidence is insufficient to establish a direct causal relationship or a class-wide adverse effect of incretin-based therapies on anemia.

“Although observational studies suggest possible associations with anemia, iron deficiency, and nutritional deficiencies in selected populations, current evidence is insufficient to establish a direct causal relationship or a class-wide adverse effect.”

The relationship between incretin-based therapies and hematological parameters is complex and heterogeneous, with findings differing across therapies, study populations, and outcomes.

“The available evidence indicates a complex and heterogeneous relationship between incretin-based therapies and hematological parameters, with findings differing across therapies, study populations, and outcomes.”

Potential pathophysiological explanations for hematological changes include micronutrient vulnerabilities due to reduced food intake, lower dietary diversity, gastrointestinal intolerance, delayed gastric emptying, and weight loss.

“Potential pathophysiological explanations include micronutrient vulnerabilities due to reduced food intake, lower dietary diversity, gastrointestinal intolerance, delayed gastric emptying, and weight loss.”

Limitations stated by the authors

The review is a narrative synthesis without formal risk-of-bias assessment or quantitative meta-analytic synthesis, and the included studies are heterogeneous in design and outcome definitions.

“As this was a narrative review, no formal risk-of-bias assessment or quantitative meta-analytic synthesis was performed; however, findings were interpreted according to study design, population characteristics, outcome definitions, and methodological limitations, and different levels of evidence were not considered equivalent.”